Amplifon (OTCMKTS:AMFPF - Get Free Report) issued its earnings results on Thursday. The company reported $0.10 EPS for the quarter, meeting the consensus estimate of $0.10, Zacks reports. Amplifon had a net margin of 3.01% and a return on equity of 15.03%. The company had revenue of $651.38 million during the quarter, compared to analysts' expectations of $650.02 million.
Amplifon Stock Performance
AMFPF remained flat at $11.21 during midday trading on Friday. The company has a fifty day simple moving average of $11.21 and a 200 day simple moving average of $12.10. Amplifon has a 52-week low of $9.46 and a 52-week high of $22.43. The stock has a market cap of $2.47 billion, a PE ratio of 30.30 and a beta of 0.68. The company has a quick ratio of 0.68, a current ratio of 0.73 and a debt-to-equity ratio of 0.38.
Wall Street Analyst Weigh In
Several analysts recently weighed in on the company. Citigroup raised Amplifon to a "buy" rating in a research note on Thursday, July 23rd. Morgan Stanley assumed coverage on shares of Amplifon in a report on Wednesday, September 2nd. They set an "overweight" rating on the stock. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy".
Read Our Latest Research Report on AMFPF
Amplifon Company Profile
(
Get Free Report)
Amplifon S.p.A. is an Italy-based hearing-care company that provides hearing solutions and related services to people with hearing loss. Its business includes the distribution and fitting of hearing aids, hearing assessments, personalized counseling, device maintenance, and after-sales support. The company also offers accessories and technologies designed to improve hearing in different environments.
Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has expanded from an Italian specialist into an international hearing-care retailer.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amplifon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.
While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.